DEF: Oxbridge Re Seeks Share Capital Boost, New Incentive Plan

Oxbridge Re Holdings Limited calls an Extraordinary General Meeting to vote on a significant increase in authorized share capital and a new omnibus incentive plan to support long-term growth and talent retention.

Summary

• Proposes increasing authorized share capital from US$50,000 (divided into 50,000,000 shares of US$0.001 par value each) to US$500,000 (divided into 500,000,000 shares of US$0.001 par value each), by the creation of an additional 450,000,000 shares.
• Seeks approval for the amendment and restatement of the Company's Third Amended and Restated Memorandum and Articles of Association to reflect the increased authorized share capital.
• Requests approval for the Oxbridge Re Holdings Limited 2025 Omnibus Incentive Plan, which will allow for the granting of equity and cash incentive awards, reserving up to 1,569,514 ordinary shares initially.
• The number of shares available under the 2025 Omnibus Incentive Plan will also increase annually on the first day of each fiscal year, beginning with the fiscal year ending December 31, 2026, and continuing until December 31, 2035, with such annual increase equal to the lesser of (i) 5% of the number of Shares outstanding on December 31st of the immediately preceding fiscal year, and (ii) an amount determined by the Board.
• As of the record date, July 25, 2025, 7,535,922 ordinary shares were issued and outstanding, with a closing price of $2.04 per share on The NASDAQ Stock Market.
• The Board of Directors unanimously recommends voting FOR all three proposals.

Sentiment

Score: 7

Explanation: The proposals are strategically positive, providing necessary flexibility for growth and talent retention. However, the significant increase in authorized shares introduces potential for future dilution, which is a negative for existing shareholders if not managed carefully. The company's financial performance (net losses) in recent years adds a layer of caution, making the need for capital flexibility more pronounced.

Positives

• Provides significant financial flexibility for future financing transactions, including public or private offerings of ordinary shares or convertible securities.
• Enables the company to pursue potential strategic transactions and acquisitions, supporting long-term growth.
• Facilitates the rapid scaling of the Company's and its subsidiaries' operations.
• Allows the company to take timely advantage of market conditions and favorable financing opportunities without the expense and delay of additional shareholder meetings.
• The 2025 Omnibus Incentive Plan is designed to attract, retain, focus, and motivate executives, employees, directors, consultants, and advisors by aligning their interests with shareholders through equity and cash incentive awards.

Negatives

• Future issuance of additional authorized ordinary shares may dilute the earnings per share of existing ordinary shares.
• Future issuance of additional authorized ordinary shares may dilute the equity and voting rights of those holding ordinary shares at the time of issuance.
• The potential dilutive effect from future share issuances may cause a reduction in the market price of ordinary shares.
• The increased number of authorized but unissued ordinary shares could, under certain circumstances, have an anti-takeover effect, although the Board states this is not the intent.

Risks

• Dilution of earnings per share and equity/voting rights for existing shareholders from future share issuances.
• Potential reduction in market price of ordinary shares due to future issuances.
• The ability to issue substantial amounts of ordinary shares without shareholder approval (except as required by law or regulation) could impede changes in control or dilute ownership of those seeking control.
• Risk of adverse tax, legal, or regulatory consequences to the Company, any subsidiary, or any other Member or its affiliates if voting rights adjustments (related to the 9.9% U.S. Member rule) are not properly implemented or maintained.
• Potential for Excise Tax on golden parachute payments under Code Section 4999 if Total Payments in connection with a Change of Control exceed certain thresholds, which could reduce the net benefit to the participant.

Future Outlook

The Board has no current plan to issue shares from the additional authorized shares immediately but anticipates future issuances for financing, strategic transactions, and employee incentives. The 2025 Omnibus Incentive Plan will allow for granting equity and cash incentive awards to eligible individuals, with shares available increasing annually until 2035. The Compensation Committee intends to consider awarding performance bonus awards to named executive officers later in fiscal 2025.

Management Comments

• Our Board has determined that it is in our best interest and in the best interest of our shareholders to increase the authorized share capital of the Company.
• The Board unanimously approved the proposed increase and declared it to be advisable and in the best interest of our Company and our shareholders.
• The Board has no current plan to issue shares from the additional authorized shares provided by the share capital increase.
• The Board believes the proposed increase in our authorized share capital is a critical component of our long-term growth strategy, and provides the financial flexibility to support the rapid scaling of the Company’s and its subsidiaries’ operations as well as enable us to pursue financings, potential strategic transactions, as well as other general corporate transactions that we believe are accretive to shareholder value.
• The Board believes that additional authorized ordinary shares will enable the Company to take timely advantage of market conditions and favorable financing and acquisition opportunities that become available to the Company by allowing the issuance of such shares without the expense and delay of another shareholder meeting.
• The Board unanimously recommends that shareholders vote FOR the ordinary resolution to increase the authorized share capital of the Company.
• The Board unanimously recommends that shareholders vote FOR the special resolution to amend and restate the Articles.
• The Board unanimously recommends that shareholders vote FOR the approval of the Company’s 2025 Omnibus Incentive Plan.
• Through our executive compensation program, we seek to align our executive officers’ interests and motivations with those of our stockholders by rewarding both short-term and long-term objectives.
• The Compensation Committee intends to consider awarding performance bonus awards to our named executive officers later in fiscal 2025.

Industry Context

The company's proposals reflect a common strategy in the financial services and reinsurance sectors to maintain capital flexibility for growth, M&A, and to attract and retain key talent through competitive equity incentive plans. The use of an independent compensation consultant and benchmarking against a peer group (including other financial, insurance, and tech-related companies) indicates an adherence to industry best practices in executive compensation and corporate governance.

Comparison to Industry Standards

• The Compensation Committee engaged Zayla Partners, LLC, an independent third-party compensation consultant, to assist in compensation and benefits matters and to identify peer group companies.
• The peer group companies used for benchmarking included: Atlantic American Corporation, Conifer Holdings, Inc., FG Financial Group, Inc., MBIA Inc., eHealth, Inc., Paysign Inc., Acacia Research Corporation, Waterstone Financial, Inc., Security National Financial Corporation, Citizens, Inc., Flexshopper Inc., Regional Management Corp., ICC Holdings, Inc., Reliance Global Group, Inc., and Oportun Financial Corporation.
• The Committee uses this benchmarking data for informational purposes and does not formulaically target a specific percentile, using performance as a primary driver of compensation levels.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for dilution from future share issuances, but also potential for value creation through strategic growth and financings enabled by increased capital flexibility. Voting rights may be adjusted for large U.S. shareholders (9.9% U.S. Member rule).
• Employees/Directors: New 2025 Omnibus Incentive Plan provides a framework for equity and cash incentive awards, aiming to attract, retain, focus, and motivate executives, employees, directors, consultants, and advisors.
• Company: Enhanced financial flexibility for strategic initiatives, mergers and acquisitions, and capital raising.

Next Steps

• Shareholders to vote on Proposal One (increase authorized share capital) at the Extraordinary General Meeting on August 28, 2025.
• Shareholders to vote on Proposal Two (amend and restate Articles of Association) at the Extraordinary General Meeting on August 28, 2025.
• Shareholders to vote on Proposal Three (approve 2025 Omnibus Incentive Plan) at the Extraordinary General Meeting on August 28, 2025.
• The Compensation Committee intends to consider awarding performance bonus awards to named executive officers later in fiscal 2025.
• Annual increase in shares available under the 2025 Omnibus Incentive Plan will begin on January 1, 2026, and continue until December 31, 2035.

Key Dates

Recommendation

The proposed share capital increase and new incentive plan are crucial for the company's long-term strategic flexibility, M&A opportunities, and talent retention, which are positive for future growth. However, the substantial increase in authorized shares introduces significant potential for dilution, which could negatively impact existing shareholder value and share price if not managed judiciously. Given the company's recent history of net losses, the need for capital is evident, but the execution of future capital raises and their impact on per-share metrics will be key. Therefore, a "hold" recommendation is appropriate, advising investors to monitor the company's strategic execution and the actual use of the newly authorized capital.

Keywords

Oxbridge Re, OXBR, SEC filing, proxy statement, share capital increase, omnibus incentive plan, equity compensation, corporate governance, shareholder meeting, dilution, capital raise, executive compensation, risk management, reinsurance